Yesim Dargaud/isth2023
Aug 14, 2025, 13:09
Thrombin Generation Assay to Guide Factor Therapy With Fitusiran
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared on X:
“Thrombin Generation Assay to Guide Co‐Administration of Factor Therapies With Fitusiran – I personally think the Thrombin Generation assays could not be used for the clinical management of the patients in non replacement therapies and only show the drug concentration”
Read the full here.
Title: Utilising Thrombin Generation Assay to Guide Co-Administration of Factor Therapies With Fitusiran
Authors: Yesim Dargaud, Christophe Nougier, Stephanie Desage, Hamdi Rezigue, Amy Dericquebourg, Yohann Jourdy, Alexandre Leuci, Anne Lienhart
Discover more on Hemostasis Today.
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology
-
Jan 9, 2026, 06:12James Caldwell on The Hidden Culprit in Perimesencephalic SAH